Hypertension
Conditions
Interventions
The intervention group will be notified that they have the salt-sensitive genotype and required to record their daily diet in "
CALO mama Plus."
In addition, information and quiz on salt reduction will be distributed for the intervention group.
The control group (1) will receive no intervention.
The control group (2) will be required to record
CALO mama Plus,"
but information and quiz on salt reduction will not be distributed. To consider the effect of simply using the app, an auxiliary comparison between the intervention group and control group (2) will be
Sponsors
Kyoto University
TOSHIBA CORPORATION, Wellmira Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Persons between 20 and 65 years of age - Those with angiotensinogen gene polymorphism (AGT M235T) - Those who have an elevated blood pressure (systolic blood pressure 120 or higher, or diastolic blood pressure 80 or higher) in a health checkup during 2022FY or 2023FY - Those who have not used "CALO mama Plus" before - Those who submitted urine and responded to the questionnaire before the intervention
Exclusion criteria
Exclusion criteria: - Pregnant or nursing mothers - Those who cannot use "CALO mama Plus" because they do not have a smartphone (iPhone or Android) - Those who cannot understand Japanese - Consenters whom the investigators deem inappropriate as subjects of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Salt intake | — |
Secondary
| Measure | Time frame |
|---|---|
| Health awareness, systolic and diastolic blood pressure, and body mass index | — |
Countries
Japan
Contacts
Public ContactKoryu Sato
Graduate School of Medicine and School of Public Health, Kyoto University Department of Social Epidemiology
Outcome results
None listed